Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 872

1.

[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].

Khouri C, Planès S, Logerot S, Villier C, Mallaret M.

Encephale. 2016 Jun;42(3):277-80. doi: 10.1016/j.encep.2016.01.001. Epub 2016 Feb 26. French.

PMID:
26923996
2.

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

Karslıoǧlu EH, Özalp E, Çayköylü A.

Clin Psychopharmacol Neurosci. 2016 Feb 29;14(1):96-100. doi: 10.9758/cpn.2016.14.1.96.

3.

Aripiprazole: A New Option in Delirium.

Prommer E.

Am J Hosp Palliat Care. 2015 Nov 20. pii: 1049909115612800. [Epub ahead of print]

PMID:
26589880
4.

Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status.

Heide J, Zhang F, Bigos KL, Mann SA, Carr VJ, Shannon Weickert C, Green MJ, Weinberger DR, Vandenberg JI.

Am J Psychiatry. 2016 Jan;173(1):53-9. doi: 10.1176/appi.ajp.2015.14050653. Epub 2015 Oct 20.

PMID:
26481172
5.

1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.

Möller D, Salama I, Kling RC, Hübner H, Gmeiner P.

Bioorg Med Chem. 2015 Sep 15;23(18):6195-209. doi: 10.1016/j.bmc.2015.07.050. Epub 2015 Aug 6.

PMID:
26299826
6.

Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.

Björkholm C, Jardemark K, Schilström B, Svensson TH.

Eur Neuropsychopharmacol. 2015 Oct;25(10):1842-7. doi: 10.1016/j.euroneuro.2015.07.002. Epub 2015 Jul 20.

PMID:
26233606
7.

Antipsychotic drugs on maternal behavior in rats.

Li M.

Behav Pharmacol. 2015 Sep;26(6):616-26. doi: 10.1097/FBP.0000000000000168. Review.

PMID:
26221833
8.

Evaluating the effect of risperidone on speech: A cross-sectional study.

Sinha P, Vandana VP, Lewis NV, Jayaram M, Enderby P.

Asian J Psychiatr. 2015 Jun;15:51-5. doi: 10.1016/j.ajp.2015.05.005. Epub 2015 May 11.

PMID:
26013669
9.

Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range.

Baba S, Enomoto T, Horisawa T, Hashimoto T, Ono M.

J Pharmacol Sci. 2015 Mar;127(3):326-31. doi: 10.1016/j.jphs.2015.01.007. Epub 2015 Feb 7.

10.

Efficacy and safety of sertindole in schizophrenia: a clinical review.

Zoccali RA, Bruno A, Muscatello MR.

J Clin Psychopharmacol. 2015 Jun;35(3):286-95. doi: 10.1097/JCP.0000000000000305. Review.

PMID:
25830594
11.

The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.

Baba S, Murai T, Nakako T, Enomoto T, Ono M, Shimizu I, Ikeda K.

Behav Brain Res. 2015;287:120-6. doi: 10.1016/j.bbr.2015.03.025. Epub 2015 Mar 21.

PMID:
25804359
12.

Clozapine and olanzapine inhibit proton currents in BV2 microglial cells.

Shin H, Kim J, Song JH.

Eur J Pharmacol. 2015 May 15;755:74-9. doi: 10.1016/j.ejphar.2015.03.003. Epub 2015 Mar 11.

PMID:
25771455
13.

Benzo- and thienobenzo- diazepines: multi-target drugs for CNS disorders.

Mendonça Júnior FJ, Scotti L, Ishiki H, Botelho SP, Da Silva MS, Scotti MT.

Mini Rev Med Chem. 2015;15(8):630-47. Review.

PMID:
25694077
14.

Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.

Ishima T, Futamura T, Ohgi Y, Yoshimi N, Kikuchi T, Hashimoto K.

Eur Neuropsychopharmacol. 2015 Apr;25(4):505-11. doi: 10.1016/j.euroneuro.2015.01.014. Epub 2015 Feb 7.

15.

Asenapine alters the activity of monoaminergic systems following its subacute and long-term administration: an in vivo electrophysiological characterization.

Oosterhof CA, El Mansari M, Blier P.

Eur Neuropsychopharmacol. 2015 Apr;25(4):531-43. doi: 10.1016/j.euroneuro.2015.01.006. Epub 2015 Jan 15.

PMID:
25656272
16.

The atypical antipsychotic clozapine selectively inhibits interleukin 8 (IL-8)-induced neutrophil chemotaxis.

Capannolo M, Fasciani I, Romeo S, Aloisi G, Rossi M, Bellio P, Celenza G, Cinque B, Cifone MG, Scarselli M, Maggio R.

Eur Neuropsychopharmacol. 2015 Mar;25(3):413-24. doi: 10.1016/j.euroneuro.2014.12.002. Epub 2014 Dec 18.

PMID:
25554564
17.

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.

Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu068. doi: 10.1093/ijnp/pyu068.

18.

Use of aripiprazole for delirium in the elderly: a short review.

Kirino E.

Psychogeriatrics. 2015 Mar;15(1):75-84. doi: 10.1111/psyg.12088. Epub 2014 Dec 17. Review.

PMID:
25514894
19.

Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.

Xu S, Gullapalli RP, Frost DO.

Schizophr Res. 2015 Feb;161(2-3):452-7. doi: 10.1016/j.schres.2014.10.034. Epub 2014 Dec 5.

20.

[Antipsychotics of different clinical/pharmacological groups in treatment of negative disorders in schizophrenia].

Danilov DS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(9):116-23. Review. Russian.

PMID:
25473665
Items per page

Supplemental Content

Loading ...
Write to the Help Desk